Learning from Patients to Develop Better Treatments

PhRMA November 22, 2016

As important stakeholders in the drug development process, patients, family members and caregivers can provide unique and valuable perspectives on their disease and available treatment options. These perspectives can inform evaluation of a medicine’s benefits and risks and provide the context for FDA’s regulatory decision making.